First Case of A859T Epidermal Growth Factor Receptor Mutation Responding to Erlotinib

被引：6
|
作者：
Le Maignan, Laureline [1 ]
Mirebeau-Prunier, Delphine [2 ]
Vervueren, Laurent [3 ]
Jeanfaivre, Thierry [1 ]
Urban, Thierry [1 ]
Hureaux, Jose [1 ]
机构：
[1] Acad Hosp, Dept Pulmonol, F-49933 Angers, France
[2] Acad Hosp, Biochem & Mol Biol Lab, F-49933 Angers, France
[3] Acad Hosp, Dept Nucl Med, F-49933 Angers, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 03期
关键词：
CELL LUNG-CANCER; GEFITINIB; IMPACT;
D O I：
10.1097/JTO.0b013e3182037c0c
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：639 / 640
页数：2
相关论文
共 50 条
  • [21] Epidermal Growth Factor Receptor Mutation and Chemosensitivity Response
    Yoshimasu, Tatsuya
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 772 - 773
  • [22] A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
    Matsumura, Sosuke
    Ano, Satoshi
    Kikuchi, Norihiro
    Masuda, Michiko
    Osawa, Hajime
    Kondo, Yuzuru
    Ishii, Yukio
    Hizawa, Nobuyuki
    SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
  • [23] ErlotinibAcquired resistance to erlotinib during treatment for non small cell lung carcinoma with epidermal growth factor receptor (EGFR) mutation: case report
    Reactions Weekly, 2018, 1717 (1) : 129 - 129
  • [24] Erlotinib/osimertinibDevelopment of resistance to epidermal growth factor receptor-tyrosine-kinase inhibitors: case report
    Reactions Weekly, 2016, 1626 (1) : 74 - 74
  • [25] Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib
    Chen, Yuh-Min
    Fan, Wen-Chien
    Tseng, Pei-Chun
    Tsai, Chun-Ming
    Chou, Teh-Ying
    Wu, Chieh-Hung
    Chou, Kun-Ta
    Lee, Yu-Chin
    Perng, Reury-Perng
    Whang-Peng, Jacqueline
    ONCOLOGY LETTERS, 2012, 3 (03) : 713 - 717
  • [26] Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine
    Akiyama, Norimichi
    Karayama, Masato
    Iwaizumi, Moriya
    Kusama, Yukiko
    Kono, Masato
    Hozumi, Hironao
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Enomoto, Noriyuki
    Fujisawa, Tomoyuki
    Nakamura, Yutaro
    Inui, Naoki
    Suda, Takafumi
    INTERNAL MEDICINE, 2017, 56 (17) : 2367 - 2371
  • [27] Targeting the epidermal growth factor receptor by erlotinib (Tarceva™) for the treatment of esophageal cancer
    Sutter, AP
    Höpfner, M
    Huether, A
    Maaser, K
    Scherübl, H
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (07) : 1814 - 1822
  • [28] Epidermal growth factor receptor status and the response of bladder carcinoma cells to erlotinib
    Jacobs, Micah A.
    Wotkowicz, Chad
    Baumgart, Egbert D.
    Neto, Brasil Silva
    Rieger-Christ, Kimberly M.
    Bernier, Trisha
    Cohen, Michael S.
    Libertino, John A.
    Summerhayes, Ian C.
    JOURNAL OF UROLOGY, 2007, 178 (04): : 1510 - 1514
  • [29] In Silico Identification of Novel Erlotinib Analogues Against Epidermal Growth Factor Receptor
    Sheikh, Ishfaq A.
    Hassan, Hani Mutlak A.
    ANTICANCER RESEARCH, 2016, 36 (11) : 6125 - 6132
  • [30] A novel method for detection of mutation in epidermal growth factor receptor
    Zhao, Jinyin
    Zhao, Jing
    Huang, Jie
    Chen, Yan
    Jiang, Jun
    Wu, Weili
    Wang, Pengzhi
    Liu, Licheng
    Li, Longyun
    Wu, Lin
    Wang, Mengzhao
    Chen, Weijun
    LUNG CANCER, 2011, 74 (02) : 226 - 232
12345